Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, ...

PRAGUE and LONDON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF ... transmembrane protein on GI cancer cells, CDH17 is ideally suited for an ADC-mediated ...